Skip to content

Syndax Pharmaceuticals SNDX Change in Other Current Assets

Change in Other Current Assets at other companies

Turning Point Brands logo
Turning Point BrandsTPB
$8.06M+49.3%
Energizer Holdings logo
Energizer HoldingsENR
$3.05M+12,100%
Winmark logo
WinmarkWINA
$19K-24.6%
AtriCure logo
AtriCureATRC
$5.16M+32.9%
SHA
SharonAI Holdings, Inc. Class A Common StockSHAZ
$1.4M+12,071%
The RealReal logo
The RealRealREAL
$167K-64.4%

Other financials

Income statement

See full
Revenue$64.9M+224%
Operating income-$34.2M+59.2%
Net income-$42.7M+49.7%
EPS (diluted)-$0.48+51.0%

Balance sheet

See full
Cash & equivalents$130.9M-15.0%
Total debt$350.5M+4.2%
Total equity$41.6M-80.6%
Total assets$472.7M-26.2%

Cash flow

See full
Operating cash flow-$50.3M+47.1%
CapEx$46.8K
Free cash flow-$80.8M-17.6%

Valuation

See full
Market cap$1.77B+95.0%

Profitability

See full
Operating margin-102.8%-47.8pp
Net margin-111.9%-51.5pp
FCF margin-187.2%-85.4pp

Returns & leverage

See full
Return on equity-189.5%-8,509pp
Debt / equity8.4×+6.9×
Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.

The official record: Syndax Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's change in other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Syndax Pharmaceuticals's change in other current assets?
Syndax Pharmaceuticals (SNDX) reported change in other current assets of $0 in Q4 2025.
How has Syndax Pharmaceuticals's change in other current assets changed year-over-year?
Syndax Pharmaceuticals's change in other current assets increased by 100.0% year-over-year, from -$115.75K to $0.
What does change in other current assets mean?
Change in miscellaneous current assets not classified in specific working capital categories.